CN101053632A - Traditional Chinese medicine for treating thromboangitis obliterans - Google Patents
Traditional Chinese medicine for treating thromboangitis obliterans Download PDFInfo
- Publication number
- CN101053632A CN101053632A CNA2006100176432A CN200610017643A CN101053632A CN 101053632 A CN101053632 A CN 101053632A CN A2006100176432 A CNA2006100176432 A CN A2006100176432A CN 200610017643 A CN200610017643 A CN 200610017643A CN 101053632 A CN101053632 A CN 101053632A
- Authority
- CN
- China
- Prior art keywords
- portions
- radix
- chinese medicine
- parts
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a Chinese medicine for treating thromboangiitis obliterans comprising the raw materials in weight portions: Chinese angelica root 3-9 portions, red peony root 1-3 portions, peach kernel 1-3 portions, safflower 1-3 portions, tetrandra root 2-3 portions, cow soapwortseed 2-3 portions, myrrh 2-3 portions, frankincense 2-3 portions, astragalus root 3-6 portions, leatherleaf milletia 2-3 portions, red sage root 2-3 portions, earthworm 1-portions, dried body of ground beetle 1-2 portions, chuanxiong rhizome 1-3 portions, licorice 1-3 portions, dendrobium stem 1-2 portions, corydalis tuber 2-3 portions, dried rehmannia root 3-9 portions, figwort root 3-9 portions, honeysuckle flower 3-9 portions, dandelion 3-9 portions, cyathula root 2-3 portions. The combination of the medicinals can warm the channels to disperse the coldness, activating blood circulation to resolve stasis, thereby curing the disease. Moreover, the medicine exerts no pain during treatment, the cost is low, the course is short and the efficacy is absent.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of thromboangiitis obliterans, belong to field of traditional Chinese.
Background technology
Thromboangiitis obliterans (TAO) is similar to " necrosis ", " gangrene of finger or toe " record of motherland's medical science, this is much sick more early stage to refer to (toe) morbidity from extremity, ten, show as numb twinge, spasm cramp, swelling, coolness of extremities or fever, red swelling of the skin livid purple, fester and suppurate.The blood stasis obturation is obstructed in the lumen of vessels, causes the ischemia necrosis, this disease disability rate height, and the case fatality rate height, pathogenic factor is more." a Ling Shu Miraculous Pivot or Divine Axis cellulitis piece of writing " point out " Fu Xuemaiying defends, circumfluence endlessly, cold-evil visitor is among passages through which vital energy circulates; then blood tears, the blood tears are then obstructed, general rule is not defended gas and is returned it; must not recur, thus the swollen cold heat-transformation of pain, then meat corruption of domination of heat; rottenness of muscle forming pus; pus does not rush down then mashed muscle, and mashed muscle is then hindered energy, and bone injury then marrow disappears ", its main diseases because of be since internal injury excited, and cause deficiency of liver-blood, and sexual strain, consumption is hindered essence and blood and deficiency of the kidney, outer severe cold is paddled, cold relaxing the bowels with purgatives of warm nature is subjected to, and injures stimulations such as smoking outward, so that the cohesion of deficiency of the liver and kindey cold-damp, stasis of blood resistance meridians numbness plug can not, QI-blood circulation does not freely form.According to the evolution difference of primary disease, can be divided into initial stage (dysfunction phase), mid-term (malnutrition phase) and later stage (gangrene phase).Vasculitic Therapeutic Method is varied, and commonly used have Chinese medicine, Western medicine, acupuncture, an amputation etc., and the Western medicine price is higher, and effect is undesirable; Though and the Chinese medicine effect is significantly better than Western medicine, the curative effect of existing Chinese medicine is also not too remarkable; Therefore, the patient is mostly by amputation at present, and this has not only caused very big misery to the patient, simultaneously, has brought a lot of inconvenience also for patient's life.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of thromboangiitis obliterans, low to reach cost, the significant purpose of therapeutic effect.
In order to achieve the above object, technical program of the present invention lies in adopting a kind of Chinese medicine for the treatment of thromboangiitis obliterans, comprised the medicament that the raw material of following parts by weight is made:
Radix Angelicae Sinensis 3-9 part Radix Paeoniae Rubra 1-3 part Semen Persicae 1-3 part Flos Carthami 1-3 part
Radix Stephaniae Tetrandrae 2-3 part king does not stay 2-3 part Myrrha 2-3 part Olibanum 2-3 part
Radix Astragali 3-6 part Caulis Spatholobi 2-3 part Radix Salviae Miltiorrhizae 2-3 part Pheretima 1-2 part
Eupolyphaga 1-2 part Rhizoma Chuanxiong 1-3 part Radix Glycyrrhizae 1-3 part Herba Dendrobii 1-2 part
Rhizoma Corydalis 2-3 part Radix Rehmanniae 3-9 part Radix Scrophulariae 3-9 part Flos Lonicerae 3-9 part
Herba Taraxaci 3-9 part Radix Cyathulae 2-3 part.
Also comprise following raw material in the described Chinese medicine:
Ramulus Cinnamomi 1-2 part Rhizoma Zingiberis 1-2 part Radix Aconiti Lateralis Preparata 1-2 part.
Also comprise following raw material in the described Chinese medicine:
Hirudo 2-3 part Herba Leonuri 3-4 part Squama Manis 1-2 part.
Also comprise following raw material in the described Chinese medicine:
Herba Violae 3-9 part Hirudo 2-3 part Squama Manis 1-2 part Scorpio 1-2 part
Scolopendra 1-2 part.
Can be any one dosage form.
Medicine of the present invention is according to the theory of Chinese medicine " blood must be trembled with fear and then be stagnated, and gets hot then capable " and blood circulation promoting and blood stasis dispelling, and is through reasonable compatibility, formulated.Each raw material among the present invention has the following advantages: Radix Angelicae Sinensis, and sweet in the mouth, suffering, warm in nature, return liver, the heart, spleen channel, sweet Wen Zhirun is the key medicine of enriching blood, and is used for the treatment of heart-liver blood deficiency, shallow complexion, dizzy cardiopalmus etc.Radix Paeoniae Rubra, the sour in the mouth hardship, cold nature, function loose carbuncle, removing fire from the liver, broken congestion, stimulate the menstrual flow and close, be applicable to pyretic toxicity carbuncle and the not all right amenorrhea of women's congestion, and the various pain that cause because of the capable retardance of blood.Semen Persicae, bitter sweet, flat.Flos Carthami, another name: shuteria pampaniniana, thorn Flos Carthami, Flos Carthami, golden red flower.Warm in nature, acrid in the mouth cures mainly the latus rectum of invigorating blood circulation, eliminating stasis to stop pain.Radix Stephaniae Tetrandrae, bitter, hot, cold, return bladder, kidney, spleen channel, wind-damp dispelling, pain relieving, diuretic.The king does not stay, and hardship is flat, goes into liver, stomach warp, promoting blood circulation to restore menstrual flow, stimulating milk secretion detumescence.Myrrha, bitter in the mouth, property is flat, is key medicine outer, traumatology, can control the traumatic injury of surgery carbuncle skin infection and traumatology, and congestion is had a pain.Olibanum, arduous, warm regulating QI is invigorated blood circulation, and pain relieving chases after poison.The Radix Astragali, sweet, tepor, tonifying Qi and lifting yang, hemostasis by invigorating QI, the QI invigorating row stagnates, blood stasis removing eliminating stagnation, benefiting QI for strengthening the superficies, QI invigorating tonifying YIN, inducing diuresis to remove edema, warming the interior cold expelling, pus expelling by strengthening vital QI granulation promoting, strong body constitution, life lengthening.Caulis Spatholobi, warm in nature, bitter but slightly sweet taste has the promoting the circulation of blood of enriching blood, the function of relaxing muscles and tendons and activating QI and blood in the collateral.Radix Salviae Miltiorrhizae, cold nature, bitter in the mouth has promoting tissue regeneration by removing blood stasis, the function of promoting blood circulation to restore menstrual flow.Pheretima, salty, cold, heat clearing away, suppressing the hyperactive liver, Zhichuan, collateral dredging.Eupolyphaga is a cold Chinese medicine, but removing blood stasis, removing mass, collateral dredging, reason are hindered.Rhizoma Chuanxiong is conventional Chinese medicine, and is warm in nature, and acrid in the mouth has the function of blood-activating and qi-promoting, wind-expelling pain-stopping.Radix Glycyrrhizae has another name called Radix Betae, honeywort, MEICAO, and property is sweet, flat, goes into liver, spleen, lung meridian, and its energy coordinating the actions of various ingredients in a prescription cures mainly vital organs of the human body cold and heat pathogen, infirmities and diseases, can lung moistening detoxifcation and middle emergency.Herba Dendrobii, another name: Lin Lan, taboo life, Du Lan, JINCHA flower, Qian Nianrun, Dendrobium denneanum Kerr., bracketplant, property: be slightly cold, sweet, return stomach, kidney channel, have reinforcing stomach reg fluid, the function of nourishing YIN and clearing away heat.Rhizoma Corydalis has another name called: Rhizoma Corydalis, Rhizoma Corydalis, and invigorate blood circulation, regulate the flow of vital energy, pain relieving.The Radix Rehmanniae, cool in nature, sweet in the mouth is gone into the heart, liver, kidney channel, can removing heat from blood, again can YIN nourishing, the effect of tool heat clearing away YIN nourishing, cooling blood for hemostasis, promoting the production of body fluid to quench thirst.Radix Scrophulariae, bitter in the mouth is salty, and is cold in nature.YIN nourishing, pathogenic fire reducing, antidotal effect are arranged, be applicable to epidemic febrile disease, the damage of cloudy liquid, thirsty vexed, the joint dysphoria with smothery sensation of sending out the speckle and the deficiency of YIN, and the laryngopharynx swelling and pain of depletion fire syndrome going up.Also can be with its tonifying kidney-yin deficiency.Flos Lonicerae, another name: Flos Lonicerae, bistrichiasis, Radix Ophiopogonis, two precious flowers, cold in nature, sweet in the mouth; Heat-clearing and toxic substances removing.Herba Taraxaci, cool in nature, mildly bitter flavor; Heat-clearing and toxic substances removing, the removing heat from blood eliminating stagnation.Radix Cyathulae: property is flat, sweet in the mouth, have dispel the wind, dampness removing, effect such as stimulate the menstrual flow, invigorate blood circulation.All medicines of the present invention share, and dispelling cold by warming the meridian, blood circulation promoting and blood stasis dispelling can make the blood vessels circulation, the disease recovery from illness.The patient uses medicine of the present invention to treat, and essentially no misery is taken like a shot and evident in efficacy, and patient's cost is low, can improve curative effect greatly, shortens the course of treatment, and the reduction expense has played positive progradation to the medical development of China.
According to the standard of relevant scientific research case, strictness filters out vasculitis patient 218 examples, in 218 examples, male 180 examples, women 38 examples, wherein early stage 80 examples, mid-terms 120 example, late periods 18 example.
Therapeutic effect
Curative effect judging standard:
(1) clinical cure: cardinal symptom disappears, and wound surface heals fully, suffers from the limb blood circulation and does not have obvious obstacle, recovers former work or general work.The rheography wave amplitude strengthens or recovers normal.
(2) produce effects: clinical cardinal symptom significantly alleviates, and color of the leather, temperature are obviously recovered, and wound surface is near healing.The rheography wave amplitude strengthens, and can do light work.
(3) take a turn for the better: clinical symptom relief or improvement, wound surface dwindles.The rheography wave amplitude strengthens or no change slightly.
(4) invalid: through 2 months no changes of treatment or the person of transferring from one hospital to another.
Therapeutic outcome:
Clinical cure 199 examples account for 91.3%; Produce effects 5 examples account for 2.3%; 10 examples that take a turn for the better account for 4.6%; Invalid 4 examples account for 1.8%, and total effective rate is up to 98.2%.
Calculated by 30 days each courses of treatment, the longest is 10 courses of treatment, and 2 examples are arranged; The shortest treatment time is 2 courses of treatment, and Most patients is received treatment and can be fully recovered 2-7 the course of treatment.
Preparation method can for: by weight each raw material is put together, is broken into the fine flour shape with pulverizer, after the sterilization, the making pellets by mixing medical powder with honey shape.
The specific embodiment
Embodiment 1
The feedstock production by following parts by weight of present embodiment forms:
2 parts of 2 parts of Radixs Stephaniae Tetrandrae of 2 parts of Flos Carthamis of 2 parts of Semen Persicaes of 4 parts of Radix Paeoniae Rubra of Radix Angelicae Sinensis
The king does not stay 2 parts of 4 portions of Caulis Spatholobis of 2 parts of Radixs Astragali of 2 parts of Olibanums of 2 parts of Myrrhas
2 parts in 2 portions of Radix Glycyrrhizaes of 1 part of Rhizoma Chuanxiong of 1 part of eupolyphaga of 2 parts of Pheretimas of Radix Salviae Miltiorrhizae
5 parts of 5 portions of Flos Loniceraes of 5 portions of Radix Scrophulariaes of 2 parts of Radix Rehmanniae of 1 part of Rhizoma Corydalis of Herba Dendrobii
3 parts of 5 portions of Radix Cyathulaes of Herba Taraxaci.
This embodiment is applicable to the patient in arbitrary period.
Embodiment 2
The Chinese medicine of present embodiment is formed by the feedstock production of following parts by weight:
2 parts of 2 parts of Radixs Stephaniae Tetrandrae of 2 parts of Flos Carthamis of 2 parts of Semen Persicaes of 4 parts of Radix Paeoniae Rubra of Radix Angelicae Sinensis
The king does not stay 2 parts of 4 portions of Caulis Spatholobis of 2 parts of Radixs Astragali of 2 parts of Olibanums of 2 parts of Myrrhas
2 parts in 2 portions of Radix Glycyrrhizaes of 1 part of Rhizoma Chuanxiong of 1 part of eupolyphaga of 2 parts of Pheretimas of Radix Salviae Miltiorrhizae
5 parts of 5 portions of Flos Loniceraes of 5 portions of Radix Scrophulariaes of 2 parts of Radix Rehmanniae of 1 part of Rhizoma Corydalis of Herba Dendrobii
2 parts of 2 parts of Radix Aconiti Lateralis Preparatas of 2 portions of Rhizoma Zingiberiss of 3 parts of Ramulus Cinnamomi of 5 portions of Radix Cyathulaes of Herba Taraxaci.
Preparation method is: each raw material of above-mentioned weight portion put together, is broken into the fine flour shape with pulverizer, and after the sterilization, the making pellets by mixing medical powder with honey shape.
Present embodiment is that the initial stage (dysfunction phase), when the patient used, effect was better.
Embodiment 3
2 parts of 2 parts of Radixs Stephaniae Tetrandrae of 2 parts of Flos Carthamis of 2 parts of Semen Persicaes of 5 parts of Radix Paeoniae Rubra of Radix Angelicae Sinensis
The king does not stay 3 parts of 5 portions of Caulis Spatholobis of 2 parts of Radixs Astragali of 3 parts of Olibanums of 3 parts of Myrrhas
3 parts in 3 portions of Radix Glycyrrhizaes of 2 parts of Rhizoma Chuanxiongs of 2 parts of eupolyphaga of 3 parts of Pheretimas of Radix Salviae Miltiorrhizae
6 parts of 6 portions of Flos Loniceraes of 6 portions of Radix Scrophulariaes of 3 parts of Radix Rehmanniae of 2 parts of Rhizoma Corydalis of Herba Dendrobii
1 part of 3 parts of Squama Manis of 2 parts of Herba Leonuris of 2 portions of Hirudos of 6 portions of Radix Cyathulaes of Herba Taraxaci.
The medicine of present embodiment is specially for mid-term (malnutrition phase), when the patient used, effect was better.
Embodiment 4
The Chinese medicine of present embodiment is formed by the feedstock production of following parts by weight:
3 parts of 3 parts of Radixs Stephaniae Tetrandrae of 3 parts of Flos Carthamis of 3 parts of Semen Persicaes of 9 parts of Radix Paeoniae Rubra of Radix Angelicae Sinensis
The king does not stay 3 parts of 6 portions of Caulis Spatholobis of 3 parts of Radixs Astragali of 3 parts of Olibanums of 3 parts of Myrrhas
3 parts in 3 portions of Radix Glycyrrhizaes of 2 parts of Rhizoma Chuanxiongs of 2 parts of eupolyphaga of 3 parts of Pheretimas of Radix Salviae Miltiorrhizae
9 parts of 9 portions of Flos Loniceraes of 9 portions of Radix Scrophulariaes of 3 parts of Radix Rehmanniae of 2 parts of Rhizoma Corydalis of Herba Dendrobii
2 parts of 3 parts of Squama Maniss of 9 portions of Hirudos of 3 portions of Herba Violaes of 9 portions of Radix Cyathulaes of Herba Taraxaci
2 parts of 2 parts of Scolopendras of Scorpio.
The medicine of present embodiment is the patient in later stage (gangrene phase) when using, and effect is better.
It should be noted last that: above embodiment is the unrestricted technical scheme of the present invention in order to explanation only, although the present invention is had been described in detail with reference to the foregoing description, those of ordinary skill in the art is to be understood that: still can make amendment or be equal to replacement the present invention, as to change of dosage form etc., and not breaking away from any modification or partial replacement of the spirit and scope of the present invention, it all should be encompassed in the middle of the claim scope of the present invention.
Claims (5)
1, a kind of Chinese medicine for the treatment of thromboangiitis obliterans is characterized in that: comprise the medicament that the raw material of following parts by weight is made:
Radix Angelicae Sinensis 3-9 part Radix Paeoniae Rubra 1-3 part Semen Persicae 1-3 part Flos Carthami 1-3 part
Radix Stephaniae Tetrandrae 2-3 part king does not stay 2-3 part Myrrha 2-3 part Olibanum 2-3 part
Radix Astragali 3-6 part Caulis Spatholobi 2-3 part Radix Salviae Miltiorrhizae 2-3 part Pheretima 1-2 part
Eupolyphaga 1-2 part Rhizoma Chuanxiong 1-3 part Radix Glycyrrhizae 1-3 part Herba Dendrobii 1-2 part
Rhizoma Corydalis 2-3 part Radix Rehmanniae 3-9 part Radix Scrophulariae 3-9 part Flos Lonicerae 3-9 part
Herba Taraxaci 3-9 part Radix Cyathulae 2-3 part.
2, the Chinese medicine of treatment thromboangiitis obliterans according to claim 1 is characterized in that: also comprise following raw material in the described Chinese medicine:
Ramulus Cinnamomi 1-2 part Rhizoma Zingiberis 1-2 part Radix Aconiti Lateralis Preparata 1-2 part.
3, the Chinese medicine of treatment thromboangiitis obliterans according to claim 1 is characterized in that: also comprise following raw material in the described Chinese medicine:
Hirudo 2-3 part Herba Leonuri 3-4 part Squama Manis 1-2 part.
4, the Chinese medicine of treatment thromboangiitis obliterans according to claim 1 is characterized in that: also comprise following raw material in the described Chinese medicine:
Herba Violae 3-9 part Hirudo 2-3 part Squama Manis 1-2 part Scorpio 1-2 part
Scolopendra 1-2 part.
5, according to the Chinese medicine of arbitrary described treatment thromboangiitis obliterans among the claim 1-4, it is characterized in that: can be any one dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100176432A CN100548350C (en) | 2006-04-13 | 2006-04-13 | A kind of Chinese medicine for the treatment of thromboangiitis obliterans |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100176432A CN100548350C (en) | 2006-04-13 | 2006-04-13 | A kind of Chinese medicine for the treatment of thromboangiitis obliterans |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101053632A true CN101053632A (en) | 2007-10-17 |
| CN100548350C CN100548350C (en) | 2009-10-14 |
Family
ID=38793798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100176432A Expired - Fee Related CN100548350C (en) | 2006-04-13 | 2006-04-13 | A kind of Chinese medicine for the treatment of thromboangiitis obliterans |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100548350C (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199614B (en) * | 2007-12-17 | 2010-06-23 | 常立国 | Medicament for treating vasculitic |
| CN101711828B (en) * | 2009-12-18 | 2011-06-01 | 李燕宁 | Decoction for promoting blood circulation |
| CN102091253A (en) * | 2011-01-13 | 2011-06-15 | 黄彬 | A kind of traditional Chinese medicine pill for treating vasculitis and its preparation process |
| CN101066335B (en) * | 2007-06-01 | 2011-11-30 | 张连仁 | Chinese medicine for treating thromboangiitis obliterans and phlebitis and its preparation method |
| CN102302629A (en) * | 2011-07-28 | 2012-01-04 | 刘文章 | Channel warming and collateral dredging medicine wine |
| CN101711813B (en) * | 2009-11-11 | 2012-01-11 | 宋爱民 | Traditional Chinese medicine pill for treating vasculitis |
| CN103330803A (en) * | 2013-07-03 | 2013-10-02 | 范青 | Chinese medicinal composition for vasculitis |
| CN103948687A (en) * | 2014-05-19 | 2014-07-30 | 辽宁中医药大学附属医院 | Medicine for preventing and treating intimal hyperplasia after damage of endarterium and preparation method thereof |
| CN104027641A (en) * | 2014-06-04 | 2014-09-10 | 烟台瑞智生物医药科技有限公司 | Traditional Chinese medicine for treating damp heat syndrome type angiitis |
| CN104042788A (en) * | 2014-06-19 | 2014-09-17 | 张金龙 | Traditional Chinese medicine composition for treating thromboangitis obliterans |
| CN104173570A (en) * | 2014-07-28 | 2014-12-03 | 首都医科大学附属北京中医医院 | Traditional Chinese medicine composition for preventing and treating myocardial damage in perioperative period of interventional therapy of coronary artery disease |
| CN104258001A (en) * | 2014-10-29 | 2015-01-07 | 庄增芹 | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans |
| CN104367980A (en) * | 2014-11-13 | 2015-02-25 | 黄志超 | Medicine for treating thromboangiitis obliterans |
| CN105435073A (en) * | 2015-12-25 | 2016-03-30 | 随钢周 | Soup capable of relieving embolism, promoting circulation of qi and dispersing blood stasis |
| CN105770475A (en) * | 2016-04-18 | 2016-07-20 | 邢明宇 | Traditional Chinese medicine composition for treating angiitis |
| CN107412681A (en) * | 2017-08-29 | 2017-12-01 | 王文春 | A kind of medicine for treating Buerger's disease and preparation method thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101401909B (en) * | 2008-10-23 | 2012-05-30 | 宋兆普 | Pill for treating arterial obliterative angiitis |
-
2006
- 2006-04-13 CN CNB2006100176432A patent/CN100548350C/en not_active Expired - Fee Related
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101066335B (en) * | 2007-06-01 | 2011-11-30 | 张连仁 | Chinese medicine for treating thromboangiitis obliterans and phlebitis and its preparation method |
| CN101199614B (en) * | 2007-12-17 | 2010-06-23 | 常立国 | Medicament for treating vasculitic |
| CN101711813B (en) * | 2009-11-11 | 2012-01-11 | 宋爱民 | Traditional Chinese medicine pill for treating vasculitis |
| CN101711828B (en) * | 2009-12-18 | 2011-06-01 | 李燕宁 | Decoction for promoting blood circulation |
| CN102091253A (en) * | 2011-01-13 | 2011-06-15 | 黄彬 | A kind of traditional Chinese medicine pill for treating vasculitis and its preparation process |
| CN102091253B (en) * | 2011-01-13 | 2012-06-20 | 黄彬 | A Chinese medicinal pill for treating angiitis, and its preparation method |
| CN102302629A (en) * | 2011-07-28 | 2012-01-04 | 刘文章 | Channel warming and collateral dredging medicine wine |
| CN103330803B (en) * | 2013-07-03 | 2015-01-07 | 范青 | Chinese medicinal composition for vasculitis |
| CN103330803A (en) * | 2013-07-03 | 2013-10-02 | 范青 | Chinese medicinal composition for vasculitis |
| CN103948687B (en) * | 2014-05-19 | 2016-03-23 | 辽宁中医药大学附属医院 | A kind of medicine and preparation method of preventing and treating neointimal hyperplasia after Artery injury |
| CN103948687A (en) * | 2014-05-19 | 2014-07-30 | 辽宁中医药大学附属医院 | Medicine for preventing and treating intimal hyperplasia after damage of endarterium and preparation method thereof |
| CN104027641A (en) * | 2014-06-04 | 2014-09-10 | 烟台瑞智生物医药科技有限公司 | Traditional Chinese medicine for treating damp heat syndrome type angiitis |
| CN104042788A (en) * | 2014-06-19 | 2014-09-17 | 张金龙 | Traditional Chinese medicine composition for treating thromboangitis obliterans |
| CN104042788B (en) * | 2014-06-19 | 2017-07-28 | 杨志丽 | A kind of Chinese medicine composition for treating Buerger's disease |
| CN104173570A (en) * | 2014-07-28 | 2014-12-03 | 首都医科大学附属北京中医医院 | Traditional Chinese medicine composition for preventing and treating myocardial damage in perioperative period of interventional therapy of coronary artery disease |
| CN104258001A (en) * | 2014-10-29 | 2015-01-07 | 庄增芹 | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans |
| CN104367980A (en) * | 2014-11-13 | 2015-02-25 | 黄志超 | Medicine for treating thromboangiitis obliterans |
| CN105435073A (en) * | 2015-12-25 | 2016-03-30 | 随钢周 | Soup capable of relieving embolism, promoting circulation of qi and dispersing blood stasis |
| CN105770475A (en) * | 2016-04-18 | 2016-07-20 | 邢明宇 | Traditional Chinese medicine composition for treating angiitis |
| CN107412681A (en) * | 2017-08-29 | 2017-12-01 | 王文春 | A kind of medicine for treating Buerger's disease and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100548350C (en) | 2009-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100548350C (en) | A kind of Chinese medicine for the treatment of thromboangiitis obliterans | |
| CN100341545C (en) | Oral medicine for treating thromboangitis obliterans | |
| CN1122243A (en) | Medicinal powder for eliminating embolism and invigorating blood circulation | |
| CN1257715A (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN104667035A (en) | Medicament for treating gout | |
| CN104127567B (en) | A kind of Chinese medicine composition for the treatment of diabetic peripheral neuropathy | |
| CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
| CN1076619C (en) | Moxiburning medicine for acupoint therapy | |
| CN100546640C (en) | A kind of Chinese medicine composition of orally taken for curing cyclomastopathy | |
| CN1299723C (en) | Medicine for treating rhomboembolia type angiitis | |
| CN101912552B (en) | Chinese medicinal preparation for treating ulcus cruris | |
| CN105561272A (en) | Traditional Chinese medicine preparation for relieving Reynolds disease and preparation method thereof | |
| CN112717096A (en) | Chinese herbal medicine foot bath powder capable of reducing uric acid and dissipating wind and tonifying kidney | |
| CN104383175A (en) | Medicine for treating chronic osteomyelitis and preparation method of medicine | |
| CN1308025C (en) | Medicine for treating paraplegia and its preparing method | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN108042744A (en) | A kind of Chinese medicine composition and preparation method for being used to treat prostatic disorders | |
| CN1404850A (en) | Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine | |
| CN1115160C (en) | Orally-applied medicine for treating hyperosteogeny | |
| CN104436036A (en) | Traditional Chinese medicine prepration for treating arthrosis like crane knees | |
| CN105797037A (en) | Traditional Chinese medicine composition for treating chronic urinary system infection | |
| CN105943989A (en) | Traditional Chinese medicine composition for treating nonliquefaction of semen | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
| CN104288612A (en) | Traditional Chinese medicine preparation for treating diabetes gangrene symptom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091014 Termination date: 20130413 |